[ad_1] Pots of Activia yoghurt, manufactured by Danone SA, sit on display. Bloomberg | Getty Images The CEO of French consumer goods giant Danone downplayed the threat of obesity drugs on its food business, arguing that consumers were likely to turn to healthy products as part of their new weight loss regime. Antoine de Saint-Affrique…
[ad_1] Weight loss drugs have been in the spotlight. But they’re just one aspect of a growing focus on health — on the part of both consumers and governments. The Covid-19 pandemic was a big factor behind the rising focus on weight and its implications for health, Morgan Stanley noted. “Thus health (or wellness) has…
[ad_1] There’s a global investing opportunity in a corner of health care that is both “significant and underappreciated,” according to Barclays. The segment is clinical nutrition, which the bank defined as an area focused on patients who need specific supplemental nutrition because of chronic health care conditions or because they are unable to eat. Barclays…
